How your liver handles fructose differently than glucose.
What the evidence says
- In mice, fructose uniquely increased SREBP1c and downstream fatty acid synthesis genes[1]
- In mice, fructose reduced liver insulin signaling, a proposed mechanism in animal work, not a demonstrated human cause[1]
- Postprandial hepatic de novo lipogenesis increased from 11.4% to 16.9% with fructose (P = 0.021), and the 16-hour AUC for fractional DNL from 21% to 104% × 16 h (P = 0.0043); fasting DNL was unaffected; no change with glucose[2]
- Fructose caused more pronounced obesity, glucose intolerance, and hepatomegaly than glucose (despite similar caloric intake)[1]
- Ketohexokinase (first fructose metabolism enzyme) elevated in obese humans with steatohepatitis[1]
- Ketohexokinase knockdown reduced liver triglycerides 30-35% and improved glucose tolerance in fructose-fed mice[1]
- Fructose effects are context-dependent: divergent harm only emerges on high-fat diet; on chow diet, no major difference from glucose[1]
- Ketohexokinase phosphorylates fructose 10 times faster than glucokinase phosphorylates glucose, and the process is insulin-independent[3]
- In the liver, ”the metabolism of fructose 1-phosphate in the liver occurs independently of phosphofructokinase, a second rate-determining step in glucose metabolism”[4]
- Fructose activates SREBP1c independent of insulin signaling — nuclear translocation occurs even in mice with liver-specific insulin receptor knockout[3]
- Following IV fructose load, hepatic ATP levels drop within 5 minutes and remain suppressed for 60+ minutes; ATP depletion leads to increased uric acid and reactive oxygen species[3]
- Replacing complex carbohydrates with fructose for 9 days increased liver fat to 137% of control (P = .016) and fractional DNL to 18.6% vs 11.0% (P = .001), at neutral energy balance with no weight change[5]
- Fructose blunted hepatic insulin suppression of endogenous glucose production within 9 days (P = .013), suggesting early hepatic insulin resistance[5]